Stanford University
Showing 3,201-3,250 of 34,515 Results
-
Christina Bradshaw
Clinical Assistant Professor, Medicine - Nephrology
Current Research and Scholarly InterestsDr. Bradshaw is interested in studying counseling practices and transitions of care among persons with advanced chronic kidney disease and end-stage renal disease in low- and middle-income countries.
-
Landon Bradshaw
MD Student with Scholarly Concentration in Health Services & Policy Research / Health Equity and Social Justice, expected graduation Winter 2029
BioLandon Bradshaw is a medical student at Stanford University School of Medicine with interests in gastroenterology-related illnesses, health policy, and advancing health equity. His work focuses on how healthcare policy and system-level structures influence access to high-quality cancer care, particularly among historically underserved populations.
He conducts health services and outcomes research in the Stanford Surgery Policy Improvement Research & Education Center (Dawes Lab), where he examines the impact of Medicaid expansion on treatment utilization and survival outcomes in metastatic colorectal cancer. His broader research interests include evaluating policy mechanisms that drive adoption of innovative evidence-based therapies and designing system-level interventions that promote equitable care delivery.
At Stanford, Landon serves as President of the Stanford Medical Student Association, the elected governing body representing nearly 600 MD and PA students. In this role, he has led institutional initiatives focused on equity, community engagement, and resource stewardship, including securing funding for large-scale service-learning programming and implementing a formalized, equity-centered framework for student organization funding.
Landon is committed to a career at the intersection of academic medicine, policy, and leadership, with the goal of shaping healthcare systems that deliver high-value, equitable care at scale. -
Brian Brady
Clinical Associate Professor, Medicine - Nephrology
BioDr. Brady is a fellowship-trained nephrologist with board certification in nephrology and in internal medicine. He is a clinical assistant professor in the Department of Medicine, Division of Nephrology, at Stanford University School of Medicine.
He provides care at the Stanford Health Care Boswell Kidney Clinic as well as the Stanford Health Care Kidney Clinic in Emeryville.
Dr. Brady is particularly interested in the management of patients with chronic kidney disease (CKD). He also treats end-stage kidney disease, hypertension, kidney stones, glomerular disease and other kidney related conditions.
His research in value-based health care focuses on methods to improve care delivery for patients with CKD and end-stage kidney disease (ESKD). He has received funding for his research from sources including the National Institutes of Health.
Dr. Brady has published his research findings in JAMA Internal Medicine the Journal of the American Society of Nephrology, and elsewhere.
He has presented invited talks on high-value care delivery to policy makers on Capitol Hill in Washington, DC. He also has made presentations to his peers at national, regional, and local meetings of kidney disease specialists.
He has delivered lectures to the Institute for Healthcare Improvement National Forum, Satellite Healthcare Home Dialysis Academy, and other meetings. He has shared his insights in presentations to faculty and students in the Division of Nephrology at Peking Union Medical College in Beijing, China.
Dr. Brady is a member of the American Society of Nephrology, International Society of Nephrology, and American College of Physicians. -
Scott Brady
Lecturer, Graduate School of Business - Other Faculty
BioScott Brady is a founding partner at Innovation Endeavors, an early stage venture capital firm with offices in Palo Alto and New York City,. Previously Scott was a serial entrepreneur and co-founded three publicly traded tech companies.
In his role as an investor, Scott looks to partner with entrepreneurs who are tackling technically difficult challenges that are capital intensive and truly transformative. These companies leverage a proliferation of data and new computation and automation tools to run more experiments; learn and iterate faster, better, and cheaper; and speed up the growth cycle.
Scott has led Innovation Endeavors investments in multiple Stanford Graduate School of Business-founded companies, including Plenty, which is driving the evolution of the $3 trillion agriculture industry with indoor, vertical farms that are powered by machine learning, data science, and automation; Clear Metal, which is leveraging AI and machine learning to clean up disorganized, dirty data in the supply chain, making it easier to predict problems and manage complexity; and Citrine, which uses AI and massive data sets to accelerate materials discovery and product development.
Prior to joining Innovation Endeavors, Scott was the chief executive officer of Slice, where he was also a co-founder and board member. Prior to working at Slice, he was co- founder and chief executive officer of FiberTower, co-founder and chief technology officer of Clarus Corp., and co-founder and chief technology officer of SQLFinancials.
Scott is also a lecturer in management at Stanford GSB, where he teaches about management and new venture formation. Additionally, he serves on the school’s Advisory Council and is chairman of the advisory board for its MSx Program.
Scott earned his master’s in management from Stanford GSB and a bachelor’s in finance, with high honors, from the University of Florida. Scott holds multiple software and technology patents. -
Sabrina Braham, MD FAAP
Clinical Assistant Professor, Pediatrics - General Pediatrics
Current Research and Scholarly InterestsDr. Braham's work focuses on bending the arc of health innovation toward equity, value, and better population health. She is interested in the development, funding and implementation of innovative care models for child and family health.
-
Margaret Brandeau
Coleman F. Fung Professor in the School of Engineering and Professor, by courtesy, of Health Policy
BioProfessor Brandeau is the Coleman F. Fung Professor in the School of Engineering and a Professor of Health Policy (by Courtesy). Her research focuses on the development of applied mathematical and economic models to support health policy decisions. Her recent work has examined programs related to HIV and drug abuse prevention and treatment, control of the opioid epidemic, and responses to homelessness. She has served as Principal Investigator or Co-PI on a broad range of funded research projects.
She is a Fellow of the Institute for Operations Research and Management Science (INFORMS) and a member of the Omega Rho International Honor Society for Operations Research and Management Science. From INFORMS she has received the President’s Award (recognizing important contributions to the welfare of society), the Pierskalla Prize (in 2001 and 2017, for research excellence in health care management science), the Philip McCord Morse Lectureship Award, the Saul Gass Expository Writing Award, and the Award for the Advancement of Women in Operations Research and the Management Sciences. She has also received the Award for Excellence in Application of Pharmacoeconomics and Health Outcomes Research from the International Society for Pharmacoeconomics and Outcomes Research, and a Presidential Young Investigator Award from the National Science Foundation, among other awards. Professor Brandeau earned a BS in Mathematics and an MS in Operations Research from MIT, and a PhD in Engineering-Economic Systems from Stanford. -
Onn Brandman
Associate Professor of Biochemistry and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsThe Brandman Lab studies how cells sense and respond to stress. We employ an integrated set of techniques including single cell analysis, mathematical modeling, genomics, structural studies, and in vitro assays.
-
Altair Brandon-Salmon
COLLEGE Lecturer, Civic, Liberal, and Global Education
BioAltair Brandon-Salmon is a lecturer in the Civic, Liberal, and Global Education (COLLEGE) programme. He is an art historian writing a book on how bombsites shaped British art and architecture during the twentieth century. More broadly, he focuses on British and American art which is intertwined with violence, memory, and mortality.
His scholarship has been published by Art History, Art Journal, and the Oxford Art Journal, written exhibition catalogue essays for the Cantor Arts Center and the Museum Barberini, and given lectures at the Courtauld Institute of Art, the University of York, and the Paul Mellon Centre for Studies in British Art. His essays have appeared in America, Commonweal, Literary Review, and Public Seminar, while his fiction has been published by The Isis and the Oxford Review of Books. He is currently editing a volume for the Roxburghe Club on the eighteenth-century antiquarian, archaeologist, and Jacobite dissident James Byres.
Brandon-Salmon was the assistant curator at Campion Hall, University of Oxford, and the curatorial assistant at the Sheldonian Theatre.
He is represented by Orli Vogt-Vincent at David Higham Associates.
Education
Ph.D., Stanford University, Art History (2024)
M.St., Christ Church, University of Oxford, History of Art (2019)
B.A., Wadham College, University of Oxford, History of Art (2018) -
Adam Brandt
Professor of Energy Science Engineering and Senior Fellow at the Precourt Institute for Energy
Current Research and Scholarly InterestsGreenhouse gas emissions, energy systems optimization, mathematical modeling of resource depletion, life cycle analysis
-
Nicholas Branigan
Casual - Non-Exempt, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
BioMy research interests are at the intersection of neuroscience, statistics, and machine learning. In my current work, I develop and apply state-space models and drift-diffusion models to study large-scale brain networks with human fMRI and rodent fiber photometry.
-
Rondeep Brar
Clinical Professor, Medicine - Hematology
BioAs the Chief Medical Officer of Cancer Care at Stanford Health Care, it is my privilege to partner with my colleagues in advancing innovative research alongside high quality, coordinated, and compassionate care.
I aim to provide high quality care in a diverse patient practice. My clinic includes all types of hematologic disorders, ranging from anemia, clotting/bleeding disorders, and low blood counts to complex malignancies such as leukemia, myelodysplastic syndrome, myeloma, and lymphoma. I aim to combine the efficiency of a private office with the complex care expected of a tertiary institution like Stanford. I value your time and strive to maintain an on-schedule clinic.
